Stelis Biopharma Private Limited announced that it has received $70 million in funding from Strides Pharma Science Limited and other investors

On March 19, 2021, Stelis Biopharma Private Limited closed the transaction. The company has raised $70 million in the transaction. The transaction was led by Family office of Promoters for $56 million and also included participation from Strides Pharma Science Limited (NSEI:STAR) for $14 million. The company has raised the round at pre-money valuation of $155 million.